Yukio NAKAMURA, Takako SUZUKI, Hideshi YAMAZAKI, and Hiroyuki KATO. 2018. “Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis”. Archives of Rheumatology 33 (2):154-59. https://doi.org/10.5606/ArchRheumatol.2018.6366.